09.05.2024 13:07:51 - dpa-AFX: *MERCK: HEALTH CANADA APPROVES KEYTRUDA + GEMCITABINE-BASED CHEMOTHERAPY FOR BILIARY TRACT CARCINOMA IN ADULTS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
MERCK CO. DL-,01 A0YD8Q Xetra 125,000 25.06.24 15:34:19 +1,800 +1,46% 125,000 125,400 123,800 123,200

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH